3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neoplasms
4
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Healthy Participants
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Solid Tumor
2
cMET-dysregulated Advanced Solid Tumors
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Solid Tumor
1
Neoplastic Cells, Circulating
1
Liver Cirrhosis
1
Drug-drug Interaction,SHR3680
1
Interventions
Magnetic Resonance Spectroscopy
4
Iodine-131
4
Sunitinib
3
dabrafenib
2
Trastuzumab
2
Thyrotropin Alfa
2
Thyroidectomy
2
Surgical Procedures, Operative
2
Gefitinib
2
Fluorodeoxyglucose F18
2
Bortezomib
2
AZD 6244
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
tumor necrosis factor-alpha, CNGRC fusion protein, human
1
trametinib
1
tipifarnib
1
tanespimycin
1
sargramostim
1
romidepsin
1
pralsetinib
1
pembrolizumab
1
pazopanib
1
motesanib diphosphate
1
mercaptoundecahydrododecaborate
1
lenvatinib
1
delta 24-sterol reductase
1
copanlisib
1
cediranib
1
aldesleukin
1
aflibercept
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thyroid Cancer, Papillary
×
Digoxin
×
Clear all
NCT05507775
2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA
Completed
8 enrolled